Literature DB >> 17446326

Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations.

Søren Persson1, Katharina E P Olsen, Steen Ethelberg, Flemming Scheutz.   

Abstract

Shiga toxin 2 (Stx2) from Shiga toxin-producing Escherichia coli (STEC) was subtyped by a method involving partial sequencing of the stxAB2 operon. Of 255 strains from the Danish STEC cohort, all 20 cases of hemolytic-uremic syndrome were associated with subtype Stx2 (11 cases), subtype Stx2c (1 case), or the two combined (8 cases).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17446326      PMCID： PMC1933035          DOI： 10.1128/JCM.02591-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  22 in total

1.  Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms.

Authors:  Alexander W Friedrich; Martina Bielaszewska; Wen-Lan Zhang; Matthias Pulz; Thorsten Kuczius; Andrea Ammon; Helge Karch
Journal:  J Infect Dis       Date:  2001-12-14       Impact factor: 5.226

2.  Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France.

Authors:  N Pradel; K Boukhors; Y Bertin; C Forestier; C Martin; V Livrelli
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792

3.  Cloning of genes determining the production of vero cytotoxin by Escherichia coli.

Authors:  G A Willshaw; H R Smith; S M Scotland; B Rowe
Journal:  J Gen Microbiol       Date:  1985-11

Review 4.  Phylogenetic diversity and similarity of active sites of Shiga toxin (stx) in Shiga toxin-producing Escherichia coli (STEC) isolates from humans and animals.

Authors:  H Asakura; S Makino; H Kobori; M Watarai; T Shirahata; T Ikeda; K Takeshi
Journal:  Epidemiol Infect       Date:  2001-08       Impact factor: 2.451

5.  Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.

Authors:  Marjut Eklund; Kirsikka Leino; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

6.  VTEC O157 subtypes associated with the most severe clinical symptoms in humans constitute a minor part of VTEC O157 isolates from Danish cattle.

Authors:  Bent Bjørn Roldgaard; Flemming Scheutz; Jeppe Boel; Søren Aabo; Anna Charlotte Schultz; Tom Cheasty; Eva Møller Nielsen; Katharina E P Olsen; Bjarke Bak Christensen
Journal:  Int J Med Microbiol       Date:  2004-10       Impact factor: 3.473

7.  Cloning and nucleotide sequencing of Vero toxin 2 variant genes from Escherichia coli O91:H21 isolated from a patient with the hemolytic uremic syndrome.

Authors:  H Ito; A Terai; H Kurazono; Y Takeda; M Nishibuchi
Journal:  Microb Pathog       Date:  1990-01       Impact factor: 3.738

8.  Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles.

Authors:  Jill K Jelacic; Todd Damrow; Gilbert S Chen; Srdjan Jelacic; Martina Bielaszewska; Marcia Ciol; Humberto M Carvalho; Angela R Melton-Celsa; Alison D O'Brien; Phillip I Tarr
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

9.  Subtyping of virulence genes in verocytotoxin-producing Escherichia coli (VTEC) other than serogroup O157 associated with disease in the United Kingdom.

Authors:  C Jenkins; G A Willshaw; J Evans; T Cheasty; H Chart; D J Shaw; G Dougan; G Frankel; H R Smith
Journal:  J Med Microbiol       Date:  2003-11       Impact factor: 2.472

10.  Virulence factors for hemolytic uremic syndrome, Denmark.

Authors:  Steen Ethelberg; Katharina E P Olsen; Flemming Scheutz; Charlotte Jensen; Peter Schiellerup; Jørgen Enberg; Andreas Munk Petersen; Bente Olesen; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883
View more
  129 in total

1.  Seropathotypes, Phylogroups, Stx subtypes, and intimin types of wildlife-carried, shiga toxin-producing escherichia coli strains with the same characteristics as human-pathogenic isolates.

Authors:  Azucena Mora; Cecilia López; Ghizlane Dhabi; Ana M López-Beceiro; Luís E Fidalgo; Eduardo A Díaz; Carlos Martínez-Carrasco; Rosalía Mamani; Alexandra Herrera; Jesús E Blanco; Miguel Blanco; Jorge Blanco
Journal:  Appl Environ Microbiol       Date:  2012-02-03       Impact factor: 4.792

Review 2.  A Toxic Environment: a Growing Understanding of How Microbial Communities Affect Escherichia coli O157:H7 Shiga Toxin Expression.

Authors:  Erin M Nawrocki; Hillary M Mosso; Edward G Dudley
Journal:  Appl Environ Microbiol       Date:  2020-11-24       Impact factor: 4.792

3.  Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.

Authors:  Alejandra Krüger; Paula M A Lucchesi; Alberto E Parma
Journal:  Appl Environ Microbiol       Date:  2010-10-29       Impact factor: 4.792

4.  Variation in virulence among clades of Escherichia coli O157:H7 associated with disease outbreaks.

Authors:  Shannon D Manning; Alifiya S Motiwala; A Cody Springman; Weihong Qi; David W Lacher; Lindsey M Ouellette; Janice M Mladonicky; Patricia Somsel; James T Rudrik; Stephen E Dietrich; Wei Zhang; Bala Swaminathan; David Alland; Thomas S Whittam
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

5.  Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture.

Authors:  Thomas E Grys; Lynne M Sloan; Jon E Rosenblatt; Robin Patel
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

6.  Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors.

Authors:  Malene Gantzhorn Pedersen; Claus Hansen; Erik Riise; Søren Persson; Katharina E P Olsen
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

7.  Prevalences of Shiga toxin subtypes and selected other virulence factors among Shiga-toxigenic Escherichia coli strains isolated from fresh produce.

Authors:  Peter C H Feng; Shanker Reddy
Journal:  Appl Environ Microbiol       Date:  2013-08-30       Impact factor: 4.792

8.  Extraintestinal pathogenic Escherichia coli carrying the Shiga Toxin gene stx2.

Authors:  A L Wester; L T Brandal; U R Dahle
Journal:  J Clin Microbiol       Date:  2013-10-09       Impact factor: 5.948

9.  A Putative Microcin Amplifies Shiga Toxin 2a Production of Escherichia coli O157:H7.

Authors:  Hillary M Mosso; Lingzi Xiaoli; Kakolie Banerjee; Maria Hoffmann; Kuan Yao; Edward G Dudley
Journal:  J Bacteriol       Date:  2019-12-06       Impact factor: 3.490

10.  Predicting the public health benefit of vaccinating cattle against Escherichia coli O157.

Authors:  Louise Matthews; Richard Reeve; David L Gally; J Chris Low; Mark E J Woolhouse; Sean P McAteer; Mary E Locking; Margo E Chase-Topping; Daniel T Haydon; Lesley J Allison; Mary F Hanson; George J Gunn; Stuart W J Reid
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.